Evidence mapPaperPMID 39559902Full record

ArticleCancer reports (Hoboken, N.J.)2024

Conservative Resolution of a Vesicovaginal Fistula Including Laser Therapy in a Patient Who Underwent Recurrent Surgery After Prior Radiotherapy for Endometrial Cancer.

Alessandro Buda, Jessica Mauro, Francesco Varvello, Jacopo Antolini, Giuseppe Di Guardia, Enrica Bar, Federica Filipello, Rodolfo Milani

Abstract readCase Reports
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alessandro BudaDivision of Gynecologic Oncology, Michele and Pietro Ferrero Hospital, Verduno, Italy.ORCID 0000-0002-7093-6862
Jessica MauroDivision of Gynecologic Oncology, Michele and Pietro Ferrero Hospital, Verduno, Italy.
Francesco VarvelloDivision of Urology, Michele and Pietro Ferrero Hospital, Verduno, Italy.
Jacopo AntoliniDivision of Urology, Michele and Pietro Ferrero Hospital, Verduno, Italy.
Giuseppe Di GuardiaDivision of Radiology, Michele and Pietro Ferrero Hospital, Verduno, Italy.
Enrica BarDivision of Gynecologic Oncology, Michele and Pietro Ferrero Hospital, Verduno, Italy.
Federica FilipelloDivision of Pathology, Michele and Pietro Ferrero Hospital, Verduno, Italy.
Rodolfo MilaniDivision of Gynecologic Oncology, Michele and Pietro Ferrero Hospital, Verduno, Italy.

Funding

Fondazione Ospedale Alba Bra ONLUS nonumber
6 · The paper itself

Abstract

backgroundIsolated vaginal vault recurrence of endometrial cancer can be treated with rescue radiotherapy. However, in previously irradiated patients, surgical resection can be considered the treatment of choice. Vesicovaginal fistulas (VVFs) sometimes complicate the surgical intervention because of the presence of massive ischemia and fibrosis of pelvic tissue from previous irradiation. Traditional strategies for the treatment of VVFs include endoscopic treatment (when feasible) or a laparoscopic, robotic, or open abdominal approach in some experiences through a transvesical route. The last approach can be associated with long inpatient hospital stays, postoperative complications, and failure, especially in obese patients. Our report proposes a conservative approach with prolonged catheterization and placement of nephrostomy tubes to treat a VVF with laser therapy of the fistula. CASE: We present the case of a woman with a second relapse of endometrial cancer at the level of the vaginal vault, after a hysterectomy and then radiotherapy for a first relapse, who underwent robotic partial colpectomy, with an intraoperative bladder lesion, which was repaired with interrupted stitches. However, the patient developed a vesicovaginal fistula. A conservative approach was initially undertaken as an alternative to the surgical repair of the fistula. After the clinical and radiological confirmation of the fistula andconsidering the patient's clinical condition, the multidisciplinary team proposed a conservative management of the fistula as an alternative to fistula surgical repair. Bladder catheter Ch 20 and bilateral nephrostomy did not completely resolve the fistula, with a minor residual linkage between the bladder and the vaginal vault after 8 months from the robotic surgery. A single/month diode laser application for 3 months was added to the conservative treatment. Cystography was negative at the end of laser sessions, and both nephrostomies were removed 1 week later. After 6 months, clinical and radiological follow-up was negative, and no further vaginal urine loss was recorded.

conclusionWe believe that conservative management of a complex vesicovaginal fistula after multiple treatments for endometrial cancer is possible. In this scenario, laser therapy can be a valuable clinical tool to improve the outcome, with reduced invasiveness for the patient.

Indexed as

Endometrial NeoplasmsLaser TherapyVesicovaginal FistulaAgedConservative TreatmentFemaleHumansHysterectomyNeoplasm Recurrence, LocalRobotic Surgical ProceduresTreatment Outcomeendometrial cancerlaser therapyprevious‐irradiationrecurrencerobotic partial colpectomyvesicovaginal fistula

Identifiers

PMID39559902
PMCPMC11574458

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.